What Grade III actually means for your knee

When a scan report lands with the words "Grade III cartilage damage", the question most patients ask is the same: how serious is that, exactly?

Both the original Outerbridge classification — developed in 1961 and extended to the whole knee by 1989 — and the modern ICRS (International Cartilage Repair Society) system place the Grade III threshold at the same anatomical point: cartilage loss that has worn through more than half the tissue's full depth, whilst the underlying subchondral bone plate remains structurally intact. Outerbridge describes this as fragmentation or fissuring greater than 0.5 inches across (roughly 1.2–1.5 cm) that reaches down to, but does not breach, the bone.

The ICRS system refines the picture into four subtypes. Grade 3A describes damage stopping above the calcified cartilage layer; 3B reaches that layer; 3C penetrates through it — a distinction that alters the biomechanical environment of the defect and can narrow which repair strategies remain viable; and 3D refers to surface blistering that conceals a similarly deep underlying lesion. These subtypes matter considerably to the surgeon planning treatment, even though patients cannot feel the difference between them.

Grade IV marks the boundary that changes everything: full-thickness loss with subchondral bone now exposed. That step increases repair complexity substantially and forecloses purely cartilage-level approaches.

One nuance worth understanding early: grading is anatomical, not symptomatic. A Grade III finding does not automatically explain pain severity — some patients with significant structural damage report mild symptoms, whilst others find more modest changes very limiting. The structural and symptom pictures must be read together.

Why cartilage damage tends to get worse, not better

Unlike a muscle tear or a ligament sprain, a cartilage defect has no blood supply to draw on. Articular cartilage is avascular — no blood vessels run through it — and it carries no nerve endings either. Both properties make it highly efficient at its mechanical job, but they come at a significant cost: the body cannot initiate the vascular-recruitment cascade it uses to repair soft tissue. There is no clotting response, no inflammatory clean-up, no cellular signal drawing progenitor cells to the site.

The practical result is that defects do not fill spontaneously. Under continued load they tend to extend — gradually eroding the structural floor between the lesion and the bone below. At Grade III, that floor still exists; once it is gone, the options narrow sharply. Watchful waiting is not a viable strategy at this stage: the question is which intervention fits the individual patient, not whether to act at all.

Who is still in the preservation window

Several factors together determine whether a patient is still within the preservation window — and most people can form a reasonable first impression before they see a specialist.

Age. The core range is 15 to 55 years. Selected patients who remain physically active up to approximately 65 may still qualify, though the case is assessed individually rather than by age alone.

Lesion pattern. Preservation is designed for focal, well-circumscribed defects — a single area of damage with healthy cartilage around it. Diffuse damage spread across more than one compartment, or bipolar lesions affecting opposing joint surfaces, shifts the clinical picture toward replacement rather than repair.

Mechanical alignment. The joint must either be normally aligned or have malalignment that can be corrected at the same time as the cartilage procedure. For medial-compartment repairs, this means combining the procedure with a high tibial osteotomy if varus exceeds 3°; isolated cartilage repair is contraindicated once varus malalignment exceeds 5°. An unresolved loading problem will work against even a technically sound repair.

Meniscus and ligaments. Both must be intact or actively repairable. Meniscal deficiency and ligamentous instability are not factors that can be managed after the fact — they must be addressed concurrently, because unresolved instability is documented to negate preservation outcomes regardless of how well the cartilage repair is executed.

Fitness and BMI. The rehabilitation following any preservation procedure is demanding. General fitness and a BMI compatible with that rehabilitation are part of the candidacy assessment.

One important sequence note: surgical assessment is appropriate only after a structured neuromuscular rehabilitation programme has been genuinely attempted. Specialist referral is the next step when conservative management has not resolved the problem — not an alternative to it.

How defect size shapes the treatment decision

Once grade is confirmed, defect area becomes the next decision variable — Grade III spans a wide size range, and the appropriate technique depends heavily on how much surface is involved.

For smaller defects, typically under 2–4 cm², microfracture and osteochondral autografting (mosaicplasty) remain well-established first-line surgical options. Both require an operating theatre and a structured post-operative rehabilitation course.

As lesion size increases, the evidence shifts. The SUMMIT trial demonstrated that matrix-induced autologous chondrocyte implantation (MACI) produces superior KOOS pain and function scores over microfracture at both two and five years for defects of 3 cm² and above. Autologous chondrocyte transplantation (ACT) is typically indicated within a 2.5–10 cm² range, with intact meniscus and cruciate ligaments as additional requirements.

A separate treatment category sits outside the surgical pathway altogether: injectable collagen scaffold procedures, delivered as outpatient, ultrasound-guided injections rather than theatre-based operations. This is a materially different type of intervention — different setting, different recovery demands, and a different mechanism (matrix-induced chondrogenesis, recruiting the patient's own progenitor cells rather than harvesting or implanting donor tissue). ChondroFiller injection, available at the London Cartilage Clinic on Harley Street, is one option within this category for appropriate Grade III lesions. Clinical assessment determines whether a given defect suits this pathway.

Across all approaches, machine-learning outcome analysis of over 1,000 cartilage procedures identifies total lesion area, number of concurrent defects, and symptom duration as among the strongest predictors of failure — alongside age and BMI. The practical implication is consistent: more treatment options remain open when assessment happens early.

What your MRI shows and what arthroscopy can confirm

An MRI report stating "Grade III" is a meaningful starting point — it establishes anatomy, identifies approximate lesion area, and helps rule out structural problems that might change the plan. What it cannot do reliably is serve as the final word for surgical staging.

MRI-based grading tools, including AMADEUS, align with arthroscopic ICRS assessment in roughly seven out of ten cases. In the remaining three, imaging either understates or overstates what is found at surgery — a gap that matters most when the clinical decision turns on a subtype distinction. Whether the lesion has breached the calcified cartilage layer (ICRS 3C) or remains above it (3A) influences which restoration approaches remain viable, and MRI cannot always settle that question.

There is an important counterpoint for patients who arrive with a concerning-looking scan report: pre-operative imaging grade does not predict post-operative KOOS, IKDC, or pain scores. In an ACI cohort, meaningful functional improvement followed surgery regardless of how the scan had been graded pre-operatively. A Grade III MRI finding, taken alone, is not a reason to self-select out of specialist assessment.

The reverse caution applies equally: a Grade III that looks contained on MRI should not be assumed stable. Lesions can progress in the interval between scan and review. For non-surgical pathways — including image-guided outpatient injection approaches — imaging still performs a confirmatory role, establishing lesion accessibility and confirming the defect is suitable for the planned procedure before anything goes ahead.

Getting assessed before the window closes

Roughly 30,000 joint preservation procedures are performed annually in the United States against 700,000 to 800,000 total knee replacements — a gap suggesting that many Grade III patients who remain within the preservation window are not reaching the right specialist in time.

The practical effect of late referral is narrowing options. Lesion chronicity is one of the strongest documented predictors of poorer outcomes following cartilage repair: the longer a Grade III defect persists unmanaged, the more likely it is to extend in area or progress towards subchondral exposure, where purely chondral restoration becomes substantially more difficult.

A preservation assessment extends well beyond lesion staging. Alignment, meniscal integrity, and ligament stability each require active evaluation — malalignment, meniscal deficiency, and ligamentous laxity each independently undermine repair outcomes regardless of the technique chosen. Where any of these is identified, corrective procedures need to be planned concurrently, not deferred.

Grade III occupies the interval between a structural problem that remains addressable and a joint heading towards replacement. Confirming the defect, addressing concomitant pathology, and selecting the appropriate restoration approach for the lesion's size and site is what preservation medicine is designed to do. The window exists; the question is whether patients are directed towards someone who can accurately assess it before it closes.

Specialist preservation assessment in London is available at the London Cartilage Clinic on Harley Street, led by Professor Paul Y. F. Lee; appointments can be booked at londoncartilage.com.

1. [1] Can the MRI-based AMADEUS Score Accurately Assess Pre-surgery Chondral Defect Severity According to ICRS? – AI4Scholar. (2022). https://doi.org/10.1186/s40634-022-00511-w https://doi.org/10.1186/s40634-022-00511-w
2. [2] ML Algorithm to Predict Failure Following Cartilage Preservation Procedures in the Knee – AI4Scholar. (2023). https://doi.org/10.1177/2325967123s00019 https://doi.org/10.1177/2325967123s00019
3. [3] The AMADEUS Score Is Not a Sufficient Predictor for Functional Outcome After ACI – AI4Scholar. (2023). https://doi.org/10.1007/s00402-023-05037-z https://doi.org/10.1007/s00402-023-05037-z